5,176 transcripts
Page 14 of 100
y9jk
Earnings call transcript
NASDAQ
2024 Q2
8 Aug 24
and uncertainties in the company's filings with the Securities and Exchange Commission, including Forms 10-K and 10-Q.
In addition, any projections
edg
Earnings call transcript
NASDAQ
2024 Q2
8 Aug 24
press release and our SEC filings, including our Form 10-Q filed today and our previously filed Form 10-K for the full year ended December 31, 2023
y7p
Earnings call transcript
NASDAQ
2024 Q2
8 Aug 24
recent Form 10-K, as filed with the Securities and Exchange Commission, copies of which are available on the SEC's website at www.sec.gov, along
7g
Earnings call transcript
NASDAQ
2024 Q2
8 Aug 24
could differ materially. You could refer to the section entitled Risk Factors on pages 16 through 36 of PDF's annual report on Form 10-K for the fiscal
tb
Earnings call transcript
NYSE
2024 Q2
8 Aug 24
Commission, including our most recent Form 10-K and 10-Q for additional information concerning factors that could cause actual results to differ materially
o32
Earnings call transcript
NASDAQ
2024 Q2
8 Aug 24
with the Securities and Exchange Commission, including, without limitation, its annual report on Form 10-K and other periodic reports, which identify specific
en
Earnings call transcript
NASDAQ
2024 Q2
8 Aug 24
filed from time to time with the SEC, including the company's latest annual report on Form 10-K and quarterly report on Form 10-Q, as well as our
j7p
Earnings call transcript
NASDAQ
2024 Q2
8 Aug 24
results. Some of those risks and uncertainties include, but are not limited to the risk factors that we have disclosed in our 10-K SEC filing.
Now
td4
Earnings call transcript
NYSE
2024 Q2
8 Aug 24
projected or implied during this call.
In particular, those described in our risk factors included in our annual report on Form 10-K for the fiscal year
kpc
Earnings call transcript
NYSE
2024 Q2
8 Aug 24
and Form 10-K for our fiscal year 2023 and in our prior SEC filings.
I'll now turn the call over to John Hopkins, NuScale's President and Chief Executive
w41p
Earnings call transcript
NYSE
2024 Q2
8 Aug 24
recently filed Annual Report on Form 10-K and in other reports subsequently filed with the U.S. Securities and Exchange Commission. Additionally
ba6
Earnings call transcript
NASDAQ
2024 Q2
8 Aug 24
Forms 10-K and 10-Q, which identify risks that may cause future actual results or events to differ materially. OncoCyte expressly disclaims any intent
0qw
Earnings call transcript
NYSE
2024 Q2
8 Aug 24
and uncertainties are described in our most recent annual report on Form 10-K and quarterly report on Form 10-Q, that has been filed with the SEC. We
k6ce
Earnings call transcript
NASDAQ
2024 Q3
8 Aug 24
results could differ materially due to a number of factors, including those outlined in our latest forms 10-K and 10-Q as filed with the Securities
p52
Earnings call transcript
NASDAQ
2024 Q2
8 Aug 24
materially from those indicated, including without limitation, those identified in the Risk Factors section of our most recent annual report on Form 10-K, our
9dz
Earnings call transcript
NASDAQ
2024 Q2
8 Aug 24
discussed in the Risk Factors section of our most recent periodic reports on Form 10-Q and 10-K. These statements speak only as of the date
hel
Earnings call transcript
NYSE
2025 Q1
8 Aug 24
from those expressed on the call. A discussion of these risks and uncertainties is included in our annual report on Form 10-K and other SEC filings. We
vur
Earnings call transcript
NYSE
2024 Q2
8 Aug 24
, including our most recently filed forms 10-K and 10-Q.
We assume no obligation to revise any forward-looking statements made on today's call. During
q9x
Earnings call transcript
NASDAQ
2024 Q2
8 Aug 24
related to today's results and in our most recent Form 10-K. Actual results may differ materially from any forward-looking statements that we make
w123
Earnings call transcript
NASDAQ
2024 Q2
8 Aug 24
in the company's SEC filings, including its annual report on Form 10-K and quarterly on Form 10-Q.
Any forward-looking statements should be considered